CP
DVAX

CenterBook Partners’s Dynavax Technologies DVAX Stock Holding History

CenterBook Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,320
Closed -$121K – 436
2023
Q1 		$121K Buy
+12,320
New +$132K 0.02% 379

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CenterBook Partners's DVAX Position: Q2 2023 in Review

CenterBook Partners sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 12,320 shares — an estimated $121K sold.

CenterBook Partners first reported a position in DVAX in Q1 2023 and held it in 1 quarter. The position peaked at $121K in Q1 2023. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • CenterBook Partners reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • CenterBook Partners sold 12,320 Dynavax Technologies shares in Q2 2023, an estimated $121K.
  • CenterBook Partners first reported a position in Dynavax Technologies in Q1 2023 and held it in 1 quarter.
  • CenterBook Partners's Dynavax Technologies position peaked at $121K in Q1 2023.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on CenterBook Partners's 13F filing for Q2 2023, filed 14 Aug 2023.